Global Compression Garments and Stockings Market Size By Type (Gradient Compression Stockings, Anti-Embolism Compression Stockings), By Application (Varicose Vein, Wound Care), By Region, And Segment...

The Global Compression Garments and Stockings Market was valued at USD 3.9 billion in 2023 and is projected to reach USD 6.8 billion by 2031, growing at a CAGR of 7.0% during the forecast period from 2023 to 2031. This market is experiencing substantial growth due to the rising prevalence of chronic venous diseases, increasing awareness about the therapeutic benefits of compression wear, and the growing geriatric population. These garments play a crucial role in post-surgical recovery, sports performance enhancement, and managing conditions like lymphedema and deep vein thrombosis (DVT).

Drivers:

1. Growing Incidence of Venous Disorders:

With the global rise in cases of varicose veins, lymphedema, and chronic venous insufficiency, the demand for compression garments and stockings is increasing steadily. These products improve blood circulation and provide relief, making them a preferred choice in therapeutic regimens.

2. Increasing Geriatric Population:

Elderly individuals are more prone to circulatory issues and musculoskeletal conditions, driving the demand for compression garments for both preventive and therapeutic purposes.

3. Post-Surgical and Sports Recovery Applications:

Compression wear is widely used in post-operative recovery to minimize swelling and improve healing. Additionally, athletes use these garments to enhance performance and reduce muscle soreness, boosting their adoption in the sports segment.

Restraints:

1. Limited Awareness in Low-Income Regions:

Despite growing adoption in developed markets, many developing regions lack awareness about the medical and performance benefits of compression wear, hindering market penetration.

2. Availability of Alternatives:

The availability of alternative treatments such as surgery or pharmaceutical solutions may restrict the growth of compression garments, especially in clinical settings.

Opportunity:

1. Technological Advancements in Fabric and Design:

Smart compression garments embedded with sensors and biofeedback features are gaining traction. These innovations offer personalized therapy and real-time monitoring, providing lucrative opportunities for manufacturers.

2. Growth in E-commerce and Direct-to-Consumer Sales:

Digital channels are facilitating broader reach and convenience in purchasing, especially for compression stockings and garments tailored for preventive or fitness use.

Market by System Type Insights:

The Graduated Compression Segment dominated the market in 2023 due to its effectiveness in treating venous conditions and its wide application in medical and sports domains. These garments apply the highest pressure at the ankle, gradually decreasing towards the top, enhancing venous return and reducing swelling.

Conversely, the Anti-Embolism Compression Segment is anticipated to register the highest growth, driven by its widespread use in post-operative settings to prevent deep vein thrombosis during extended bed rest or surgeries.

Market by End-use Insights:

Hospitals & Clinics accounted for the largest market share in 2023, as compression garments are a standard prescription for managing vascular conditions post-surgery. Retail Pharmacies and E-commerce are emerging as fastest-growing channels, owing to consumer preference for convenience and discreet purchase options.

Market by Regional Insights:

North America led the global compression garments and stockings market in 2023, supported by a well-established healthcare infrastructure, high awareness levels, and strong insurance reimbursement policies. Asia-Pacific, particularly countries like China, Japan, and India, is projected to experience the fastest growth, driven by the rising healthcare investments, increasing disposable incomes, and expanding aging population.

Competitive Scenario:

Leading players in the global market include Medi GmbH & Co. KG, Sigvaris Group, BSN Medical (Essity AB), 2XU Pty Ltd, Juzo, Thuasne, Leonisa SA, and Nike Inc. These companies are focusing on product diversification, material innovations, and expanding their online presence to cater to both clinical and lifestyle segments.

Key Developments:

2023: Medi GmbH introduced a new line of eco-friendly graduated compression stockings using sustainable yarn technology.

2024: Sigvaris Group launched a wearable compression sensor system for remote monitoring of patients with venous insufficiency.

2025: BSN Medical announced a strategic partnership with e-commerce platforms in North America to boost direct-to-consumer sales of its compression wear.

Scope of Work – Global Compression Garments and Stockings Market

Report Metric Details

Market Size (2023) USD 3.9 billion

Projected Market Size (2031) USD 6.8 billion

CAGR (2023–2031) 7.0%

Market Segments By System Type (Graduated, Anti-Embolism), By End-Use (Hospitals & Clinics, Retail Pharmacies, E-commerce), By Region

Growth Drivers Rising incidence of venous disorders, expanding elderly population, increasing post-surgical applications

Opportunities Smart compression garments, growth in e-commerce

FAQs:

1. What is the current market size of the Global Compression Garments and Stockings Market?

The market was valued at USD 3.9 billion in 2023.

2. What is the major growth driver of the Global Compression Garments and Stockings Market?

The primary growth driver is the rising prevalence of chronic venous disorders and increased demand for post-operative and athletic recovery solutions.

3. Which is the largest region during the forecast period in the Global Compression Garments and Stockings Market?

North America is expected to remain the largest region throughout the forecast period.

4. Which segment accounted for the largest market share in Global Compression Garments and Stockings Market?

The Graduated Compression segment held the largest share in 2023.

5. Who are the key market players in the Global Compression Garments and Stockings Market?

Major players include Medi GmbH & Co. KG, Sigvaris Group, BSN Medical, 2XU Pty Ltd, and Thuasne.